Get notified when INBS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (new) — The company explicitly states substantial doubt about its ability to continue as a going concern for at least the next twelve months, and its auditor has included an explanatory paragraph to that effect.
Intelligent Bio Solutions launches at-the-market offering of up to $3.97M at $3.44/share, netting $3.6M
Filed March 23, 2026 · ~1 min read
Key Changes
-
high
Company may sell up to $3,966,316 of common stock through an at-the-market offering with Ladenburg, at market prices.
The Offering verify on EDGAR → -
high
Assuming 1,152,998 shares sold at $3.44, net proceeds to the company are approximately $3.64 million after commissions and expenses.
The Offering verify on EDGAR → -
high
New investors face immediate dilution of $1.27 per share, as pro forma net tangible book value per share after the offering is $2.17.
Dilution verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SAR 10-Q) is open in full — no account needed.
Partner
Trade INBS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify